Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All miscellaneous studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchSelect treatment..Select..
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

 

Impact of corticosteroid doses on prognosis of severe and critical COVID-19 patients with Omicron variant infection: a propensity score matching study

Wang et al., Inflammopharmacology, doi:10.1007/s10787-024-01520-0
Aug 2024  
  Post
  Facebook
Share
  Source   PDF  
Mortality -23% Improvement Relative Risk Corticosteroids  Wang et al.  LATE TREATMENT Is late treatment with corticosteroids beneficial for COVID-19? PSM retrospective 780 patients in China (November 2022 - February 2023) Higher mortality with corticosteroids (p=0.028) c19early.org Wang et al., Inflammopharmacology, Aug 2024 Favorshigh dose Favorslow dose 0 0.5 1 1.5 2+
Retrospective 1,167 severe/critical COVID-19 patients in China showing higher 28-day mortality with higher doses of corticosteroids (>50mg/day prednisone equivalent) compared to usual doses (30-50mg/day). The type of corticosteroid used did not affect outcomes. Authors suggest that higher doses of corticosteroids may lead to poorer prognosis for severe/critical COVID-19 patients with Omicron infection in the ICU, possibly due to a milder inflammatory response with Omicron.
risk of death, 23.4% higher, HR 1.23, p = 0.03, treatment 260, control 520, adjusted per study, propensity score matching, multivariable, Cox proportional hazards.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Wang et al., 9 Aug 2024, retrospective, China, peer-reviewed, 14 authors, study period 1 November, 2022 - 11 February, 2023. Contact: drzhanqy@163.com.
This PaperMiscellaneousAll
Impact of corticosteroid doses on prognosis of severe and critical COVID-19 patients with Omicron variant infection: a propensity score matching study
Shiyao Wang, Ziying Chen, Xinran Zhang, Xiaojing Wu, Yuqiong Wang, Qi Zhang, Linna Huang, Xiaoyang Cui, Ying Cai, Xu Huang, Jingen Xia, Sichao Gu, Min Li, Qingyuan Zhan
Inflammopharmacology, doi:10.1007/s10787-024-01520-0
Background There is lack of research on corticosteroid use for severe and critical COVID-19 patients with Omicron variant infection. Methods This multi-center retrospective cohort study involved 1167 patients from 59 ICUs across the mainland of China diagnosed with severe or critical SARS-CoV-2 Omicron variant infection between November 1, 2022, and February 11, 2023. Patients were segregated into two groups based on their corticosteroid treatment-usual dose (equivalent prednisone dose 30-50 mg/day) and higher dose (equivalent prednisone dose > 50 mg/day). The primary outcome was 28-day ICU mortality. Propensity score matching was used to compare outcomes between cohorts. Results After propensity score matching, 520 patients in the usual dose corticosteroid group and 260 patients in the higher dose corticosteroid group were included in the analysis, respectively. The mortality was significantly higher in the higher dose corticosteroid group (67.3%, 175/260) compared to the usual dose group (56.0%, 291/520). Logistic regression showed that higher doses of corticosteroids were significantly associated with increased mortality at 28-day (OR = 1.62,95% CI 1.19-2.21, p = 0.002) and mortality in ICU stay (OR = 1.66,95% CI 1.21-2.28, p = 0.002). Different types of corticosteroids did not affect the effect. Conclusions The study suggests that higher-dose corticosteroids may lead to a poorer prognosis for severe and critical COVID-19 patients with Omicron variant infection in the ICU. Further research is needed to determine the appropriate corticosteroid dosage for these patients.
Author contributions SW, ZC and QZ conceived of the study. SW, XW and QZ participated in the design of the study and coordination. LH, XC, YC, XH, JX, SG, and ML participated in the enrolment of the cases. SW, ZC, YW, and QZ participated in the data collection. SW, XZ performed the statistical analysis. SW drafted the manuscript. All authors read and approved the final manuscript. Declarations Ethics approval The study protocol was approved by the Research Ethics Commission of China-Japan Friendship Hospital (2019-79-K51-1) . This study was performed in accordance with the Declaration of Helsinki. Conflict of interests The authors have no relevant financial or nonfinancial interests to disclose. Consent to participate Written informed consent was waived. Consent to publish Not applicable. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted..
References
Angus, Derde, Al-Beidh, Annane, Arabi et al., Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the remap-cap covid-19 corticosteroid domain randomized clinical trial, JAMA
Bojkova, Widera, Ciesek, Wass, Michaelis et al., Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates, Cell Res
Bouzid, Visseaux, Kassasseya, Daoud, Fémy et al., Comparison of patients infected with delta versus omicron covid-19 variants presenting to paris emergency departments : a retrospective cohort study, Ann Intern Med
Català, Coma, Alonso, Andrés, Blanco et al., Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: a cohort study and ecological analysis, Front Public Health
China, Management protocol for COVID-19
De Prost, Audureau, Heming, Gault, Pham et al., Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19, Nat Commun
Defilippis, Chapman, Mills, De Lemos, Arbab-Zadeh et al., Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury, Circulation
Do, Manabe, Vu, Nong, Fujikura et al., Clinical characteristics and mortality risk among critically ill patients with COVID-19 owing to the B.1.617.2 (Delta) variant in Vietnam: a retrospective observational study, PLoS ONE, doi:10.1371/journal.pone.0279713
Du, Tang, Gao, Wu, Meng et al., Omicron adopts a different strategy from Delta and other variants to adapt to host, Signal Transduct Target Ther
Granholm, Kjaer, Munch, Myatra, Vijayaraghavan et al., Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia, Inten Care Med
Grasselli, Greco, Zanella, Albano, Antonelli et al., Risk factors associated with mortality among patients with covid-19 in intensive care units in lombardy, Italy JAMA Intern Med
Group, Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial, Lancet
Health, COVID-19 Treatment Guidelines
Horby, Lim, Emberson, Mafham, Bell et al., Dexamethasone in hospitalized patients with covid-19, N Engl J Med
Iuliano, Brunkard, Boehmer, Peterson, Adjei et al., Trends in disease severity and health care utilization during the early omicron variant period compared with previous sars-cov-2 high transmission periods -united states, december 2020-january 2022, MMWR Morb Mortal Wkly Rep
Jung, Wernly, Fjølner, Bruno, Dudzinski et al., Steroid use in elderly critically ill COVID-19 patients, Eur Respir J, doi:10.1183/13993003.00979-2021
Katz, Altshuler, Papadopoulos, Amoroso, Goldenberg et al., The use of high-dose corticosteroids versus low-dose corticosteroids with and without tocilizumab in covid-19 acute respiratory distress syndrome, Ann Pharmacother
Kellum, Lameire, Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1), Crit Care
Lamers, Haagmans, SARS-CoV-2 pathogenesis, Nat Rev Microbiol
Lauring, Tenforde, Chappell, Gaglani, Ginde et al., Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study, BMJ
Munch, Myatra, Vijayaraghavan, Saseedharan, Benfield et al., Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with covid-19 and severe hypoxemia: the covid steroid 2 randomized trial, JAMA
Organization, Therapeutics and COVID-19: living guideline
Piralla, Mojoli, Pellegrinelli, Ceriotti, Valzano et al., Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to, Respir Med Res
Rhodes, Evans, Alhazzani, Levy, Antonelli et al., Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016, Intensive Care Med
Salvarani, Massari, Costantini, Merlo, Mariani et al., Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial, Eur Respir J, doi:10.1183/13993003.00025-2022
Shen, Liu, Shang, Xie, Li et al., Incidence and etiology of drug-induced liver injury in mainland China, Gastroenterology
Sterne, Murthy, Diaz, Slutsky, Villar et al., Association between administration of systemic corticosteroids and mortality among critically ill patients with covid-19: a meta-analysis, JAMA
Tomazini, Maia, Cavalcanti, Berwanger, Rosa et al., Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and covid-19: the codex randomized clinical trial, JAMA
Toroghi, Abbasian, Nourian, Davoudi-Monfared, Khalili et al., Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial, Pharmacol Rep
Wu, Chen, Cai, Xia, Zhou et al., Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China JAMA Intern Med
Yaqoob, Greenberg, Hwang, Lee, Vernik et al., Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit, J Med Virol
{ 'indexed': {'date-parts': [[2024, 9, 22]], 'date-time': '2024-09-22T04:16:31Z', 'timestamp': 1726978591238}, 'reference-count': 31, 'publisher': 'Springer Science and Business Media LLC', 'issue': '5', 'license': [ { 'start': { 'date-parts': [[2024, 8, 9]], 'date-time': '2024-08-09T00:00:00Z', 'timestamp': 1723161600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by/4.0'}, { 'start': { 'date-parts': [[2024, 8, 9]], 'date-time': '2024-08-09T00:00:00Z', 'timestamp': 1723161600000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by/4.0'}], 'funder': [ { 'name': 'National High Level Hospital Clinical Research Funding', 'award': ['2022-NHLHCRF-LX-01-01']}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2024, 10]]}, 'abstract': '<jats:title>Abstract</jats:title><jats:sec>\n' ' <jats:title>Background</jats:title>\n' ' <jats:p>There is lack of research on corticosteroid use for severe and ' 'critical COVID-19 patients with Omicron variant infection.</jats:p>\n' ' </jats:sec><jats:sec>\n' ' <jats:title>Methods</jats:title>\n' ' <jats:p>This multi-center retrospective cohort study involved 1167 patients ' 'from 59 ICUs across the mainland of China diagnosed with severe or critical SARS-CoV-2 ' 'Omicron variant infection between November 1, 2022, and February 11, 2023. Patients were ' 'segregated into two groups based on their corticosteroid treatment—usual dose (equivalent ' 'prednisone dose 30–50\xa0mg/day) and higher dose (equivalent prednisone dose\u2009&gt;\u2009' '50\xa0mg/day). The primary outcome was 28-day ICU mortality. Propensity score matching was ' 'used to compare outcomes between cohorts.</jats:p>\n' ' </jats:sec><jats:sec>\n' ' <jats:title>Results</jats:title>\n' ' <jats:p>After propensity score matching, 520 patients in the usual dose ' 'corticosteroid group and 260 patients in the higher dose corticosteroid group were included ' 'in the analysis, respectively. The mortality was significantly higher in the higher dose ' 'corticosteroid group (67.3%, 175/260) compared to the usual dose group (56.0%, 291/520). ' 'Logistic regression showed that higher doses of corticosteroids were significantly associated ' 'with increased mortality at 28-day (OR\u2009=\u20091.62,95% CI 1.19–2.21, ' '<jats:italic>p</jats:italic>\u2009=\u20090.002) and mortality in ICU stay (OR\u2009=\u2009' '1.66,95% CI 1.21–2.28, <jats:italic>p</jats:italic>\u2009=\u20090.002). Different types of ' 'corticosteroids did not affect the effect.</jats:p>\n' ' </jats:sec><jats:sec>\n' ' <jats:title>Conclusions</jats:title>\n' ' <jats:p>The study suggests that higher-dose corticosteroids may lead to a ' 'poorer prognosis for severe and critical COVID-19 patients with Omicron variant infection in ' 'the ICU. Further research is needed to determine the appropriate corticosteroid dosage for ' 'these patients.</jats:p>\n' ' </jats:sec>', 'DOI': '10.1007/s10787-024-01520-0', 'type': 'journal-article', 'created': {'date-parts': [[2024, 8, 9]], 'date-time': '2024-08-09T09:12:22Z', 'timestamp': 1723194742000}, 'page': '3347-3356', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Impact of corticosteroid doses on prognosis of severe and critical COVID-19 patients with ' 'Omicron variant infection: a propensity score matching study', 'prefix': '10.1007', 'volume': '32', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-1066-4850', 'authenticated-orcid': False, 'given': 'Shiyao', 'family': 'Wang', 'sequence': 'first', 'affiliation': []}, {'given': 'Ziying', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xinran', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiaojing', 'family': 'Wu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yuqiong', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Qi', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Linna', 'family': 'Huang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiaoyang', 'family': 'Cui', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ying', 'family': 'Cai', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xu', 'family': 'Huang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jingen', 'family': 'Xia', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sichao', 'family': 'Gu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Min', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-0021-0270', 'authenticated-orcid': False, 'given': 'Qingyuan', 'family': 'Zhan', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2024, 8, 9]]}, 'reference': [ { 'issue': '13', 'key': '1520_CR1', 'doi-asserted-by': 'publisher', 'first-page': '1317', 'DOI': '10.1001/jama.2020.17022', 'volume': '324', 'author': 'DC Angus', 'year': '2020', 'unstructured': 'Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A et al (2020) ' 'Effect of hydrocortisone on mortality and organ support in patients with ' 'severe COVID-19: the remap-cap covid-19 corticosteroid domain randomized ' 'clinical trial. JAMA 324(13):1317–1329', 'journal-title': 'JAMA'}, { 'issue': '3', 'key': '1520_CR2', 'doi-asserted-by': 'publisher', 'first-page': '319', 'DOI': '10.1038/s41422-022-00619-9', 'volume': '32', 'author': 'D Bojkova', 'year': '2022', 'unstructured': 'Bojkova D, Widera M, Ciesek S, Wass MN, Michaelis M, Cinatl J Jr (2022) ' 'Reduced interferon antagonism but similar drug sensitivity in Omicron ' 'variant compared to Delta variant of SARS-CoV-2 isolates. Cell Res ' '32(3):319–321', 'journal-title': 'Cell Res'}, { 'issue': '6', 'key': '1520_CR3', 'doi-asserted-by': 'publisher', 'first-page': '831', 'DOI': '10.7326/M22-0308', 'volume': '175', 'author': 'D Bouzid', 'year': '2022', 'unstructured': 'Bouzid D, Visseaux B, Kassasseya C, Daoud A, Fémy F, Hermand C et al ' '(2022) Comparison of patients infected with delta versus omicron ' 'covid-19 variants presenting to paris emergency departments\u202f: a ' 'retrospective cohort study. Ann Intern Med 175(6):831–837', 'journal-title': 'Ann Intern Med'}, { 'key': '1520_CR4', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fpubh.2022.961030', 'volume': '10', 'author': 'M Català', 'year': '2022', 'unstructured': 'Català M, Coma E, Alonso S, Andrés C, Blanco I, Antón A et al (2022) ' 'Transmissibility, hospitalization, and intensive care admissions due to ' 'omicron compared to delta variants of SARS-CoV-2 in Catalonia: a cohort ' 'study and ecological analysis. Front Public Health 10:961030', 'journal-title': 'Front Public Health'}, { 'key': '1520_CR5', 'unstructured': 'China, N. H. C. o. t. P. s. R. o. (2023). Management protocol for ' 'COVID-19. Retrieved 5 January 2023, from ' 'https://www.gov.cn/zhengce/zhengceku/2023-01/06/5735343/files/5844ce04246b431dbd322d8ba10afb48.pdf'}, { 'issue': '1', 'key': '1520_CR6', 'doi-asserted-by': 'publisher', 'first-page': '6025', 'DOI': '10.1038/s41467-022-33801-z', 'volume': '13', 'author': 'N de Prost', 'year': '2022', 'unstructured': 'de Prost N, Audureau E, Heming N, Gault E, Pham T, Chaghouri A et al ' '(2022) Clinical phenotypes and outcomes associated with SARS-CoV-2 ' 'variant Omicron in critically ill French patients with COVID-19. Nat ' 'Commun 13(1):6025', 'journal-title': 'Nat Commun'}, { 'issue': '20', 'key': '1520_CR7', 'doi-asserted-by': 'publisher', 'first-page': '1661', 'DOI': '10.1161/CIRCULATIONAHA.119.040631', 'volume': '140', 'author': 'AP DeFilippis', 'year': '2019', 'unstructured': 'DeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby ' 'LK et al (2019) Assessment and treatment of patients with type 2 ' 'myocardial infarction and acute nonischemic myocardial injury. ' 'Circulation 140(20):1661–1678', 'journal-title': 'Circulation'}, { 'key': '1520_CR8', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0279713', 'author': 'TV Do', 'year': '2023', 'unstructured': 'Do TV, Manabe T, Vu GV, Nong VM, Fujikura Y, Phan D et al (2023) ' 'Clinical characteristics and mortality risk among critically ill ' 'patients with COVID-19 owing to the B.1.617.2 (Delta) variant in ' 'Vietnam: a retrospective observational study. PLoS ONE. ' 'https://doi.org/10.1371/journal.pone.0279713', 'journal-title': 'PLoS ONE'}, { 'issue': '1', 'key': '1520_CR9', 'doi-asserted-by': 'publisher', 'first-page': '45', 'DOI': '10.1038/s41392-022-00903-5', 'volume': '7', 'author': 'X Du', 'year': '2022', 'unstructured': 'Du X, Tang H, Gao L, Wu Z, Meng F, Yan R et al (2022) Omicron adopts a ' 'different strategy from Delta and other variants to adapt to host. ' 'Signal Transduct Target Ther 7(1):45', 'journal-title': 'Signal Transduct Target Ther'}, { 'issue': '5', 'key': '1520_CR10', 'doi-asserted-by': 'publisher', 'first-page': '580', 'DOI': '10.1007/s00134-022-06677-2', 'volume': '48', 'author': 'A Granholm', 'year': '2022', 'unstructured': 'Granholm A, Kjær MN, Munch MW, Myatra SN, Vijayaraghavan BKT, Cronhjort ' 'M et al (2022) Long-term outcomes of dexamethasone 12 mg versus 6 mg in ' 'patients with COVID-19 and severe hypoxaemia. Inten Care Med ' '48(5):580–589', 'journal-title': 'Inten Care Med'}, { 'issue': '10', 'key': '1520_CR11', 'doi-asserted-by': 'publisher', 'first-page': '1345', 'DOI': '10.1001/jamainternmed.2020.3539', 'volume': '180', 'author': 'G Grasselli', 'year': '2020', 'unstructured': 'Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G et al ' '(2020) Risk factors associated with mortality among patients with ' 'covid-19 in intensive care units in lombardy. Italy JAMA Intern Med ' '180(10):1345–1355', 'journal-title': 'Italy JAMA Intern Med'}, { 'issue': '10387', 'key': '1520_CR12', 'doi-asserted-by': 'publisher', 'first-page': '1499', 'DOI': '10.1016/S0140-6736(23)00510-X', 'volume': '401', 'author': 'R. C', 'year': '2023', 'unstructured': 'Group, R. C (2023) Higher dose corticosteroids in patients admitted to ' 'hospital with COVID-19 who are hypoxic but not requiring ventilatory ' 'support (RECOVERY): a randomised, controlled, open-label, platform ' 'trial. Lancet 401(10387):1499–1507', 'journal-title': 'Lancet'}, { 'key': '1520_CR13', 'unstructured': 'Health, N. I. o. (2023). COVID-19 Treatment Guidelines. Retrieved April ' '20, 2023, from ' 'https://www.covid19treatmentguidelines.nih.gov/therapies/immunomodulators/corticosteroids/'}, { 'issue': '8', 'key': '1520_CR14', 'doi-asserted-by': 'publisher', 'first-page': '693', 'DOI': '10.1056/NEJMoa2021436', 'volume': '384', 'author': 'P Horby', 'year': '2021', 'unstructured': 'Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L et al (2021) ' 'Dexamethasone in hospitalized patients with covid-19. N Engl J Med ' '384(8):693–704', 'journal-title': 'N Engl J Med'}, { 'issue': '4', 'key': '1520_CR15', 'doi-asserted-by': 'publisher', 'first-page': '146', 'DOI': '10.15585/mmwr.mm7104e4', 'volume': '71', 'author': 'AD Iuliano', 'year': '2022', 'unstructured': 'Iuliano AD, Brunkard JM, Boehmer TK, Peterson E, Adjei S, Binder AM et ' 'al (2022) Trends in disease severity and health care utilization during ' 'the early omicron variant period compared with previous sars-cov-2 high ' 'transmission periods - united states, december 2020-january 2022. MMWR ' 'Morb Mortal Wkly Rep 71(4):146–152', 'journal-title': 'MMWR Morb Mortal Wkly Rep'}, { 'key': '1520_CR16', 'doi-asserted-by': 'publisher', 'DOI': '10.1183/13993003.00979-2021', 'author': 'C Jung', 'year': '2021', 'unstructured': 'Jung C, Wernly B, Fjølner J, Bruno RR, Dudzinski D, Artigas A et al ' '(2021) Steroid use in elderly critically ill COVID-19 patients. Eur ' 'Respir J. https://doi.org/10.1183/13993003.00979-2021', 'journal-title': 'Eur Respir J'}, { 'issue': '1', 'key': '1520_CR17', 'doi-asserted-by': 'publisher', 'first-page': '5', 'DOI': '10.1177/10600280221094571', 'volume': '57', 'author': 'A Katz', 'year': '2023', 'unstructured': 'Katz A, Altshuler D, Papadopoulos J, Amoroso N, Goldenberg R, Tarras E ' 'et al (2023) The use of high-dose corticosteroids versus low-dose ' 'corticosteroids with and without tocilizumab in covid-19 acute ' 'respiratory distress syndrome. Ann Pharmacother 57(1):5–15', 'journal-title': 'Ann Pharmacother'}, { 'issue': '1', 'key': '1520_CR18', 'doi-asserted-by': 'publisher', 'first-page': '204', 'DOI': '10.1186/cc11454', 'volume': '17', 'author': 'JA Kellum', 'year': '2013', 'unstructured': 'Kellum JA, Lameire N (2013) Diagnosis, evaluation, and management of ' 'acute kidney injury: a KDIGO summary (Part 1). Crit Care 17(1):204', 'journal-title': 'Crit Care'}, { 'issue': '5', 'key': '1520_CR19', 'doi-asserted-by': 'publisher', 'first-page': '270', 'DOI': '10.1038/s41579-022-00713-0', 'volume': '20', 'author': 'MM Lamers', 'year': '2022', 'unstructured': 'Lamers MM, Haagmans BL (2022) SARS-CoV-2 pathogenesis. Nat Rev Microbiol ' '20(5):270–284', 'journal-title': 'Nat Rev Microbiol'}, { 'key': '1520_CR20', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj-2021-069761', 'volume': '376', 'author': 'AS Lauring', 'year': '2022', 'unstructured': 'Lauring AS, Tenforde MW, Chappell JD, Gaglani M, Ginde AA, McNeal T et ' 'al (2022) Clinical severity of, and effectiveness of mRNA vaccines ' 'against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in ' 'the United States: prospective observational study. BMJ 376:e069761', 'journal-title': 'BMJ'}, { 'issue': '18', 'key': '1520_CR21', 'doi-asserted-by': 'publisher', 'first-page': '1807', 'DOI': '10.1001/jama.2021.18295', 'volume': '326', 'author': 'MW Munch', 'year': '2021', 'unstructured': 'Munch MW, Myatra SN, Vijayaraghavan BKT, Saseedharan S, Benfield T, ' 'Wahlin RR et al (2021) Effect of 12 mg vs 6 mg of dexamethasone on the ' 'number of days alive without life support in adults with covid-19 and ' 'severe hypoxemia: the covid steroid 2 randomized trial. JAMA ' '326(18):1807–1817', 'journal-title': 'JAMA'}, { 'key': '1520_CR22', 'unstructured': 'Organization, W. H. (2023). Therapeutics and COVID-19: living guideline. ' 'Retrieved 13 January 2023, from ' 'https://apps.who.int/iris/rest/bitstreams/1449398/retrieve'}, { 'key': '1520_CR23', 'volume': '83', 'author': 'A Piralla', 'year': '2023', 'unstructured': 'Piralla A, Mojoli F, Pellegrinelli L, Ceriotti F, Valzano A, Grasselli G ' 'et al (2023) Impact of SARS-CoV-2 Omicron and Delta variants in patients ' 'requiring intensive care unit (ICU) admission for COVID-19, Northern ' 'Italy, December 2021 to January 2022. Respir Med Res 83:100990', 'journal-title': 'Respir Med Res'}, { 'issue': '3', 'key': '1520_CR24', 'doi-asserted-by': 'publisher', 'first-page': '304', 'DOI': '10.1007/s00134-017-4683-6', 'volume': '43', 'author': 'A Rhodes', 'year': '2017', 'unstructured': 'Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R et al ' '(2017) Surviving sepsis campaign: international guidelines for ' 'management of sepsis and septic shock: 2016. Intensive Care Med ' '43(3):304–377', 'journal-title': 'Intensive Care Med'}, { 'key': '1520_CR25', 'doi-asserted-by': 'publisher', 'DOI': '10.1183/13993003.00025-2022', 'author': 'C Salvarani', 'year': '2022', 'unstructured': 'Salvarani C, Massari M, Costantini M, Merlo DF, Mariani GL, Viale P et ' 'al (2022) Intravenous methylprednisolone pulses in hospitalised patients ' 'with severe COVID-19 pneumonia: a double-blind, randomised, ' 'placebo-controlled trial. Eur Respir J. ' 'https://doi.org/10.1183/13993003.00025-2022', 'journal-title': 'Eur Respir J'}, { 'issue': '8', 'key': '1520_CR26', 'doi-asserted-by': 'publisher', 'first-page': '2230', 'DOI': '10.1053/j.gastro.2019.02.002', 'volume': '156', 'author': 'T Shen', 'year': '2019', 'unstructured': 'Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M et al (2019) Incidence and ' 'etiology of drug-induced liver injury in mainland China. ' 'Gastroenterology 156(8):2230-2241.e2211', 'journal-title': 'Gastroenterology'}, { 'issue': '13', 'key': '1520_CR27', 'doi-asserted-by': 'publisher', 'first-page': '1330', 'DOI': '10.1001/jama.2020.17023', 'volume': '324', 'author': 'JAC Sterne', 'year': '2020', 'unstructured': 'Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC et al ' '(2020) Association between administration of systemic corticosteroids ' 'and mortality among critically ill patients with covid-19: a ' 'meta-analysis. JAMA 324(13):1330–1341', 'journal-title': 'JAMA'}, { 'issue': '13', 'key': '1520_CR28', 'doi-asserted-by': 'publisher', 'first-page': '1307', 'DOI': '10.1001/jama.2020.17021', 'volume': '324', 'author': 'BM Tomazini', 'year': '2020', 'unstructured': 'Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC et ' 'al (2020) Effect of dexamethasone on days alive and ventilator-free in ' 'patients with moderate or severe acute respiratory distress syndrome and ' 'covid-19: the codex randomized clinical trial. JAMA 324(13):1307–1316', 'journal-title': 'JAMA'}, { 'issue': '1', 'key': '1520_CR29', 'doi-asserted-by': 'publisher', 'first-page': '229', 'DOI': '10.1007/s43440-021-00341-0', 'volume': '74', 'author': 'N Toroghi', 'year': '2022', 'unstructured': 'Toroghi N, Abbasian L, Nourian A, Davoudi-Monfared E, Khalili H, ' 'Hasannezhad M et al (2022) Comparing efficacy and safety of different ' 'doses of dexamethasone in the treatment of COVID-19: a three-arm ' 'randomized clinical trial. Pharmacol Rep 74(1):229–240', 'journal-title': 'Pharmacol Rep'}, { 'issue': '7', 'key': '1520_CR30', 'doi-asserted-by': 'publisher', 'first-page': '934', 'DOI': '10.1001/jamainternmed.2020.0994', 'volume': '180', 'author': 'C Wu', 'year': '2020', 'unstructured': 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S et al (2020) Risk factors ' 'associated with acute respiratory distress syndrome and death in ' 'patients with coronavirus disease 2019 pneumonia in Wuhan. China JAMA ' 'Intern Med 180(7):934–943', 'journal-title': 'China JAMA Intern Med'}, { 'issue': '1', 'key': '1520_CR31', 'doi-asserted-by': 'publisher', 'first-page': '349', 'DOI': '10.1002/jmv.27351', 'volume': '94', 'author': 'H Yaqoob', 'year': '2022', 'unstructured': 'Yaqoob H, Greenberg D, Hwang F, Lee C, Vernik D, Manglani R et al (2022) ' 'Comparison of pulse-dose and high-dose corticosteroids with no ' 'corticosteroid treatment for COVID-19 pneumonia in the intensive care ' 'unit. J Med Virol 94(1):349–356', 'journal-title': 'J Med Virol'}], 'container-title': 'Inflammopharmacology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s10787-024-01520-0.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s10787-024-01520-0/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s10787-024-01520-0.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 9, 21]], 'date-time': '2024-09-21T16:08:12Z', 'timestamp': 1726934892000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s10787-024-01520-0'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 8, 9]]}, 'references-count': 31, 'journal-issue': {'issue': '5', 'published-print': {'date-parts': [[2024, 10]]}}, 'alternative-id': ['1520'], 'URL': 'http://dx.doi.org/10.1007/s10787-024-01520-0', 'relation': {}, 'ISSN': ['0925-4692', '1568-5608'], 'subject': [], 'container-title-short': 'Inflammopharmacol', 'published': {'date-parts': [[2024, 8, 9]]}, 'assertion': [ { 'value': '30 October 2023', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '23 January 2024', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '9 August 2024', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'The study protocol was approved by the Research Ethics Commission of ' 'China-Japan Friendship Hospital (2019-79-K51-1). This study was performed in ' 'accordance with the Declaration of Helsinki.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Ethics approval'}}, { 'value': '\xa0The authors have no relevant financial or non-financial interests to ' 'disclose.', 'order': 3, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Conflict of interests'}}, { 'value': 'Written informed consent was waived.', 'order': 4, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Consent to participate'}}, { 'value': 'Not applicable.', 'order': 5, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Consent to publish'}}]}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit